-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Neutral on Minerva Neurosciences, Maintains $5 Price Target

Benzinga·02/26/2025 12:32:50
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $5 price target.